Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Progressive Scan Camera

By Drug Discovery Trends Editor | November 2, 2012

Toshiba Imaging, a leading manufacturer of ultra-compact high definition (HD) and high resolution CCD and CMOS video cameras, introduces the IK-TF series of progressive scan cameras for color area scan machine vision applications. The IK-TF5P2 features VGA, 659 x 494 pixel output at 59.94 frames per second (fps); the IK-TF7P2 delivers XGA, 1024 x 768 pixel output at 29.18 fps. The compact, one-piece cameras replace Toshiba’s legacy IK-TF camera series. The enhanced 3CCD progressive scan camera family features improved performance with expanded digital processing capabilities.

Economically-priced, the new camera series integrates Power over Camera Link (PoCL), digital output and reduced power requirements. Both the electronic shutter and white balance can be controlled manually or in auto mode. For added flexibility, the partial scanning function increases frame rates up to 250 fps. Other features include electronic noise reduction, digital shading correction, dual power input (PoCL or 12VDC), C-mount lens mount and both on-screen and remote RS-232 control.

Toshiba’s IK-TF5P2 and IK-TF7P2 provide precise color accuracy, improved sensitivity, and high resolution of fast-moving objects. Due to Toshiba’s proprietary three-chip prism design, the new cameras are ideal for color area scan applications in machine vision, inspection, process control, and factory automation.

Toshiba Imaging


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE